ASX - By Stock
|
ATH Biotech |
Re:
Orphan drug week - 22nd to 26th April
|
|
FiveCent
|
24 |
6.2K |
2 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
24
|
6.2K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Orphan drug week - 22nd to 26th April
|
|
FiveCent
|
24 |
6.2K |
4 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
24
|
6.2K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Orphan drug week - 22nd to 26th April
|
|
FiveCent
|
24 |
6.2K |
2 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
24
|
6.2K
|
2
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt Secures Funding
|
|
FiveCent
|
23 |
7.2K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
23
|
7.2K
|
3
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt Secures Funding
|
|
FiveCent
|
23 |
7.2K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
23
|
7.2K
|
2
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt Secures Funding
|
|
FiveCent
|
23 |
7.2K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
23
|
7.2K
|
0
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Additional Bunyu Graphite Testing Underway
|
|
FiveCent
|
18 |
4.4K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
18
|
4.4K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Additional Bunyu Graphite Testing Underway
|
|
FiveCent
|
18 |
4.4K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
18
|
4.4K
|
4
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Quarterly Activities Report - March 2024
|
|
FiveCent
|
4 |
3.8K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
4
|
3.8K
|
7
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Additional Bunyu Graphite Testing Underway
|
|
FiveCent
|
18 |
4.4K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
18
|
4.4K
|
7
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Ceasing to be a substantial holder
|
|
FiveCent
|
16 |
7.1K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
16
|
7.1K
|
0
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Quarterly Activities Report - March 2024
|
|
FiveCent
|
4 |
3.8K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
4
|
3.8K
|
11
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Quarterly Activities Report - March 2024
|
|
FiveCent
|
4 |
3.8K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
4
|
3.8K
|
11
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
FiveCent
|
22 |
5.8K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
22
|
5.8K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
FiveCent
|
22 |
5.8K |
9 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
5.8K
|
9
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Change of Director's Interest Notice x 3
|
|
FiveCent
|
14 |
3.8K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
14
|
3.8K
|
4
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Change of Director's Interest Notice x 3
|
|
FiveCent
|
14 |
3.8K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
14
|
3.8K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Change of Director's Interest Notice x 3
|
|
FiveCent
|
14 |
3.8K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
14
|
3.8K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
another good day in New York
|
|
FiveCent
|
24 |
6.5K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
24
|
6.5K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Week ahead - 15th April - 19th April
|
|
FiveCent
|
31 |
9.6K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
31
|
9.6K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Week ahead - 15th April - 19th April
|
|
FiveCent
|
31 |
9.6K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
31
|
9.6K
|
3
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Change in substantial holding
|
|
FiveCent
|
8 |
4.2K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
8
|
4.2K
|
5
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Change in substantial holding
|
|
FiveCent
|
8 |
4.2K |
7 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
8
|
4.2K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
FiveCent
|
29 |
8.0K |
6 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
29
|
8.0K
|
6
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Change in substantial holding
|
|
FiveCent
|
8 |
4.2K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
8
|
4.2K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
FiveCent
|
29 |
8.0K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
8.0K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
FiveCent
|
29 |
8.0K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
8.0K
|
5
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Ceasing to be a substantial holder
|
|
FiveCent
|
16 |
7.1K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
16
|
7.1K
|
5
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Ceasing to be a substantial holder
|
|
FiveCent
|
16 |
7.1K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
16
|
7.1K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Ceasing to be a substantial holder
|
|
FiveCent
|
16 |
7.1K |
6 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
16
|
7.1K
|
6
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Growth strategy underpinned by robust Reserves
|
|
FiveCent
|
35 |
21K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
35
|
21K
|
2
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Ceasing to be a substantial holder
|
|
FiveCent
|
16 |
7.1K |
6 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
16
|
7.1K
|
6
|
|
ASX - By Stock
|
FLN |
Re:
Ann: 2023 Results Commentary
|
|
FiveCent
|
24 |
8.4K |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
24
|
8.4K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Ceasing to be a substantial holder
|
|
FiveCent
|
16 |
7.1K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
16
|
7.1K
|
0
|
|
ASX - By Stock
|
VRC |
Re:
Non diluting Capital Raising Coming - Ha
|
|
FiveCent
|
10 |
3.4K |
7 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
10
|
3.4K
|
7
|
|
ASX - By Stock
|
VRC |
Re:
Non diluting Capital Raising Coming - Ha
|
|
FiveCent
|
10 |
3.4K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
10
|
3.4K
|
3
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Growth strategy underpinned by robust Reserves
|
|
FiveCent
|
35 |
21K |
7 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
35
|
21K
|
7
|
|
ASX - By Stock
|
VRC |
Re:
Non diluting Capital Raising Coming - Ha
|
|
FiveCent
|
10 |
3.4K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
10
|
3.4K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
FiveCent
|
113 |
26K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
113
|
26K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
FiveCent
|
113 |
26K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
113
|
26K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
FiveCent
|
113 |
26K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
113
|
26K
|
4
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Growth strategy underpinned by robust Reserves
|
|
FiveCent
|
35 |
21K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
35
|
21K
|
1
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt and AETC Enter into Agreement
|
|
FiveCent
|
44 |
17K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
44
|
17K
|
3
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Growth strategy underpinned by robust Reserves
|
|
FiveCent
|
35 |
21K |
8 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
35
|
21K
|
8
|
|
ASX - By Stock
|
VRC |
Re:
Ann: Volt and AETC Enter into Agreement
|
|
FiveCent
|
44 |
17K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
44
|
17K
|
5
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Growth strategy underpinned by robust Reserves
|
|
FiveCent
|
35 |
21K |
5 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
35
|
21K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
FiveCent
|
113 |
26K |
7 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
113
|
26K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
|
|
FiveCent
|
113 |
26K |
5 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
113
|
26K
|
5
|
|
ASX - By Stock
|
VRC |
Re:
FUTURE POTENTIAL V3
|
|
FiveCent
|
723 |
243K |
2 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
723
|
243K
|
2
|
|
ASX - By Stock
|
GMD |
Re:
Ann: Growth strategy underpinned by robust Reserves
|
|
FiveCent
|
35 |
21K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
35
|
21K
|
7
|
|